The De-Extincting Science in Jurassic World Is Right Around the Corner
By Maddie Stone,
Gizmodo
| 06. 10. 2015
Untitled Document
Twenty five years ago, Michael Crichton captured our imaginations with the crazy idea that scientists might one day resurrect dinosaurs. But on the eve of Jurassic World’s release a quarter century later, the prospect of bringing back extinct creatures is looking a lot less science fictional.
We’ll probably never bring back Tyrannosaurus rex. (Mosquitos with perfectly preserved dino DNA in their guts are a bit like magical leprechauns, though scientists did recently discover what they believe is dinosaur blood in fossils). But for species we’ve driven extinct in recent history, from the passenger pigeon to the Chinese river dolphin to the gastric brooding frog and even the woolly mammoth, we may yet be able to reverse time, thanks to incredible advances in genomics and synthetic biology.
In tribute to our undying love for massive reptilian killing machines, and the impossible dream that they’ll one day rule the Earth again, let’s explore the science of de-extincting life.
Awakening the Dead
On a midsummer’s day in 2003, a group of Spanish and French scientists helped a goat...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Robert Resta, The DNA Exchange | 07.22.2024
Medical geneticists and genetic counselors have an often complicated and at times tense relationship with people with disabilities, their families, advocates, and scholars. Geneticists are strong advocates and supporters for all of their patients, regardless of their abilities and disabilities...
By Katherine Bourzac, Nature | 07.10.2024
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...